Teva Will Appeal Loss In Vigamox Eyecare Patent Suit
Teva Pharmaceuticals USA Inc., having come out on the losing end in a three-year infringement struggle with Alcon Inc. over a patent related to the anti-bacterial eye drop drug Vigamox, has...To view the full article, register now.
Already a subscriber? Click here to view full article